Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

ChemoSen3D

ChemoSen3D uses 3D bioprinting technology to rapidly develop clinical assays for personalized medicine.
2018
2-10
Houston, Texas, United States
BiotechnologynologyLife ScienceMedicalPersonal HealthPrecision Medicine

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

165.K

Last Funding Amount

165.K

Last Funding Date

24-02-2021

Startup Stage

Seed